News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
679,733 Results
Type
Article (38823)
Company Profile (248)
Press Release (640662)
Section
Business (203577)
Career Advice (1979)
Deals (35348)
Drug Delivery (79)
Drug Development (80663)
Employer Resources (167)
FDA (16035)
Job Trends (14781)
News (343850)
Policy (32416)
Tag
Academia (2529)
Africa (712)
Alliances (48984)
Alzheimer's disease (1153)
Approvals (15968)
Arizona (174)
Artificial intelligence (76)
Asia (36835)
Australia (5992)
Bankruptcy (350)
Best Places to Work (11325)
Biosimilars (65)
Biotechnology (178)
C2C Services and Suppliers (78790)
California (2005)
Canada (976)
Cancer (552)
Career advice (1649)
Cell therapy (133)
China (159)
Clinical research (63357)
Collaboration (170)
Colorado (83)
Compensation (89)
Connecticut (80)
COVID-19 (2493)
Cystic fibrosis (78)
Data (423)
Diabetes (90)
Diagnostics (5988)
Drug pricing (70)
Earnings (83676)
Employer resources (142)
Europe (78751)
Events (107953)
Executive appointments (166)
FDA (16309)
Florida (289)
Funding (170)
Gene therapy (99)
GLP-1 (518)
Government (4300)
Healthcare (18616)
Hotbed/Location (480946)
Illinois (267)
Indiana (151)
Infectious disease (2528)
Inflammatory bowel disease (93)
Interviews (306)
IPO (16205)
Job creations (3618)
Job search strategy (1413)
Kansas (94)
Layoffs (396)
Legal (7832)
Lung cancer (118)
Manufacturing (98)
Maryland (419)
Massachusetts (1619)
Medical device (13060)
Medtech (13065)
Mergers & acquisitions (19031)
Metabolic disorders (267)
Michigan (126)
Minnesota (218)
Neuroscience (1323)
New Jersey (616)
New York (630)
NextGen Class of 2024 (6481)
Non-profit (4457)
North Carolina (597)
Northern California (878)
Obesity (162)
Ohio (111)
Opinion (172)
Patents (77)
Pennsylvania (605)
People (55887)
Phase I (19623)
Phase II (27897)
Phase III (20857)
Pipeline (122)
Postmarket research (2549)
Preclinical (8330)
Press Release (64)
Radiopharmaceuticals (230)
Rare diseases (148)
Real estate (5883)
Recruiting (63)
Regulatory (21263)
Research institute (2304)
Resumes & cover letters (347)
South America (1085)
Southern California (815)
Startups (3559)
Texas (257)
United States (9002)
Vaccines (486)
Washington State (257)
Weight loss (135)
Date
Last 7 days (565)
Last 30 days (2441)
Last 365 days (36749)
2024 (26837)
2023 (40074)
2022 (51173)
2021 (55712)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32111)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26346)
2012 (28570)
2011 (29263)
2010 (27328)
679,733 Results for "perosphere inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Perosphere Technologies Adds Dr. Michael Grosso to Advisory Board
Perosphere Technologies today announced Michael A. Grosso, MD, FACS, joins its Advisory Board.
May 20, 2024
·
3 min read
Business
Perosphere Technologies Appoints Michelle Brennan to Board of Directors
Perosphere Technologies, a private medical technologies company focused on developing next-generation coagulation diagnostics, announced the appointment of Michelle Brennan to its Board of Directors.
August 2, 2023
·
3 min read
Policy
Perosphere Technologies Awarded Federal Grants for Point-of-Care Coagulometer
Perosphere Technologies has announced the receipt of two prestigious federal grants: a Direct Phase II Small Business Innovation Research grant from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, and a subaward through an Atlanta Center for Microsystems Engineered Point-of-Care Technologies Center Grant, funded by the National Institute of Biomedical Imaging and Bioengineering.
September 19, 2023
·
2 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Pharm Country
Perosphere Technologies Announces CE-IVD Marking of the Perosphere Technologies PoC Coagulometer System for DOAC and Heparin Testing
Perosphere Technologies Inc. today announced CE (Conformité Européene)-IVD Marking of its Point-of-Care (PoC) Coagulometer System.
May 7, 2021
·
3 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Lophos Holdings Inc. Announces the Completion of Securities Purchase Agreement with ThreeD Capital Inc.
Lophos Holdings Inc. (CSE: MESC) (“Lophos” or the “Company”), a Canadian bioscience company focused on the cultivation and sale of Lophophora williamsii (“Peyote”) and ThreeD Capital Inc. (CSE: IDK) (OTCQB: IDKFF) (“ThreeD”), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, are pleased to announce the completion of its previously announced Securities Purchase Agreement (the “Agreement”).
June 20, 2024
·
4 min read
Vivos Inc. Submits the Application to the FDA for Authority to Initiate Human Clinical Trials
Vivos Inc. (OTCQB: RDGL), Vivos Inc. filed the application for an Investigational Device Exemption (“IDE”).
June 28, 2024
·
4 min read
Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.®
Merit Medical Systems, Inc., a global leader of healthcare technology, announced it has executed an asset purchase agreement with EndoGastric Solutions, Inc. for a total cash consideration of approximately $105 million.
July 1, 2024
·
18 min read
Press Releases
ReCerise Therapeutics Inc. Selected for Government Project by MOTIE
Initiates Development of Tailored Innovative Targeted Therapy for Refractory Cancer ReCerise Therapeutics Inc., has announced its selection for a grant from the Ministry of Trade, Industry and Energy of South Korea.
July 1, 2024
·
2 min read
1 of 67,974
Next